- Home
- GENK vs SCNX Comparison
GENK vs SCNX Comparison
Compare GENK & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENK
- SCNX
- Stock Information
- Founded
- GENK 2011
- SCNX 2010
- Country
- GENK United States
- SCNX United States
- Employees
- GENK N/A
- SCNX N/A
- Industry
- GENK Restaurants
- SCNX Other Pharmaceuticals
- Sector
- GENK Consumer Discretionary
- SCNX Health Care
- Exchange
- GENK Nasdaq
- SCNX Nasdaq
- Market Cap
- GENK 36.5M
- SCNX 33.6M
- IPO Year
- GENK 2023
- SCNX 2020
- Fundamental
- Price
- GENK $5.46
- SCNX $3.03
- Analyst Decision
- GENK Strong Buy
- SCNX
- Analyst Count
- GENK 3
- SCNX 0
- Target Price
- GENK $13.17
- SCNX N/A
- AVG Volume (30 Days)
- GENK 61.2K
- SCNX 10.8K
- Earning Date
- GENK 03-05-2025
- SCNX 02-25-2025
- Dividend Yield
- GENK N/A
- SCNX N/A
- EPS Growth
- GENK 483.78
- SCNX N/A
- EPS
- GENK 0.17
- SCNX 3.55
- Revenue
- GENK $198,834,000.00
- SCNX N/A
- Revenue This Year
- GENK $14.66
- SCNX $1,085.75
- Revenue Next Year
- GENK $21.47
- SCNX N/A
- P/E Ratio
- GENK $31.63
- SCNX $1.37
- Revenue Growth
- GENK 12.50
- SCNX 166.67
- 52 Week Low
- GENK $5.41
- SCNX $3.01
- 52 Week High
- GENK $14.46
- SCNX $44.56
- Technical
- Relative Strength Index (RSI)
- GENK 18.69
- SCNX N/A
- Support Level
- GENK $5.50
- SCNX N/A
- Resistance Level
- GENK $6.42
- SCNX N/A
- Average True Range (ATR)
- GENK 0.31
- SCNX 0.00
- MACD
- GENK -0.04
- SCNX 0.00
- Stochastic Oscillator
- GENK 3.94
- SCNX 0.00
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc is an Asian casual dining restaurant in the United States. It offers an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.